lorazepam has been researched along with alpidem in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lader, M; Morton, S | 1 |
| Borison, RL; Diamond, BI; Kaffeman, M; Nguyen, H; O'Neal, E; Ochs, R | 1 |
| Eich, FX; Engel, RR; Ferguson, E; Hippius, H; Kapfhammer, H; Satzger, W | 1 |
| Grünberger, J; Linzmayer, L; Saletu, B | 1 |
| Allen, D; Baylav, A; Lader, M | 1 |
| O'Hanlon, JF; Swijgman, HF; Uiterwijk, MM; van Veggel, LM; Vermeeren, A | 1 |
1 review(s) available for lorazepam and alpidem
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for lorazepam and alpidem
| Article | Year |
|---|---|
Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Female; Galvanic Skin Response; Humans; Imidazoles; Lorazepam; Male; Memory; Middle Aged; Psychiatric Status Rating Scales; Pyridines; Reaction Time | 1992 |
A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Female; Humans; Imidazoles; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales; Pyridines; Single-Blind Method | 1991 |
Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Amnesia; Anti-Anxiety Agents; Attention; Cognition; Discrimination, Psychological; Double-Blind Method; Emotions; Female; Humans; Imidazoles; Lorazepam; Male; Memory; Pyridines; Random Allocation; Reference Values | 1990 |
Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Attention; Blood Pressure; Brain; Cognition; Double-Blind Method; Electroencephalography; Female; Humans; Imidazoles; Kinetics; Lorazepam; Male; Memory; Microcomputers; Psychometrics; Pulse; Pyridines; Reaction Time | 1986 |
A comparative study of the interaction of alcohol with alpidem, lorazepam and placebo in normal subjects.
Topics: Affect; Drug Synergism; Electroencephalography; Ethanol; Evoked Potentials, Auditory; Female; Humans; Imidazoles; Lorazepam; Male; Mental Recall; Placebos; Pyridines; Reaction Time; Visual Perception | 1988 |
Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Attention; Automobile Driving; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Imidazoles; Lorazepam; Middle Aged; Naphthyridines; Ondansetron; Piperazines; Psychomotor Performance; Pyridines; Sulfur Compounds | 1995 |
1 other study(ies) available for lorazepam and alpidem
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |